| Assay ID | Title | Year | Journal | Article |
|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1795505 | Kinase Inhibition Assay from Article 10.1021/jm00018a008: \\Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibito | 1995 | Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
| Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth fa |
| AID1795540 | Kinase Inhibition Assay from Article 10.1021/jm9503613: \\Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure-Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth | 1996 | Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
| Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. |
| AID320960 | Inhibition of EGFR | 2008 | Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
| Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model. |
| AID69421 | Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles | 1996 | Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
| Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. |
| AID552424 | Agonist activity at human recombinant cannabinoid CB2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay | 2011 | Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
| Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists. |
| AID66602 | Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells. | 1995 | Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
| Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth fa |
| AID1057952 | Inhibition of human BCRP expressed in MDCK2 cells assessed as pheophorbide A accumulation treated 30 mins before pheophorbide A addition measured up to 120 mins by flow cytometry | 2013 | Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
| Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2). |
| AID552423 | Agonist activity at human recombinant cannabinoid CB2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay relative to HU-210 | 2011 | Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
| Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists. |
| AID1057953 | Inhibition of human BCRP expressed in MDCK2 cells assessed as Hoechst 33342 accumulation treated 30 mins before Hoechst 33342 addition measured up to 120 mins by fluorescence assay | 2013 | Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
| Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2). |
| AID552422 | Agonist activity at human recombinant cannabinoid CB2 receptor expressed in CHO cells at 10 uM by [35S]GTPgammaS binding assay | 2011 | Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
| Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists. |
| AID552425 | Antagonist activity at rat cannabinoid CB1 receptor in Wistar rat cerebellar membranes at 10 uM by [35S]GTPgammaS binding assay | 2011 | Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
| Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists. |
| AID493017 | Wombat Data for BeliefDocking | 1995 | Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
| Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth fa |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |